Archive for the ‘spread’ tag
Humalog – Questions and answers
Ron Davis, Pharm.D.
Customers have questions?
You’re used to answering just about any question customers come up with.
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Betaferon – syringe snake
If efficacy is too painful to take, where’s the efficacy?
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Betaferon – part of the crowd
To be with my mates, to be part of the crowd, to be myself
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Intuniv – launch 3-page print ad
Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD
Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD
To see all of the ads from this campaign, click here
Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009
To see all of this brand’s ads on AdPharm, click here
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Invega Sustenna – Rethink
Now approved
For acute and maintenance treatment of schizophrenia
Rethink the way you treat
New Once-Monthly Invega Sustenna
Brand name: Invega Sustenna
Generic name/category: paliperidone palmitate, atypical antipsychotic
Company: Janssen
Country/Market: USA, North America
Indication(s)/use: acute and maintenance treatment of schizophrenia in adults
Target: Healthcare Professionals (HCP)
Tagline: Rethink the way you treat
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Psychiatric Services – November 2009
To see all of this brand's ads on AdPharm, click here
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Seroquel XR
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Aloxi
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
